dobesilic acid
Small moleculeexperimental
Calcium dobesilate is a vasoprotective. It is the calcium salt of dobesilic acid. It is a synthetic molecule with the ability to reduce capillary permeability in the body. In Switzerland the drug is sold by the pharmaceutical company OM Pharma under the trade name of Doxium in capsules containing 500 mg of active ingredient. — Wikipedia
Clinical trial activity
6 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
3
Earliest trial started Nov 21, 2012 (NCT03962296)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
- Agranulocytosis · Phase 2/Phase 3
- COVID-19 · Phase 2
- Diabetic Retinopathy · Phase 4
- Endometrial Neoplasms · Phase 2/Phase 3
- Gastrointestinal Diseases · Phase 2/Phase 3
- Hemorrhage · Phase 2/Phase 3
- Hypersensitivity · Phase 2/Phase 3
- Kidney Failure, Chronic · Phase 4
- Menorrhagia · Phase 2/Phase 3
- Uterine Hemorrhage · Phase 2/Phase 3
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Loading structure…
SMILES
O=S(=O)(O)c1cc(O)ccc1O- Mol. weight
- 190.18 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCalcium dobesilate ↗
- ChEMBLCHEMBL1232131 ↗
Also known as
- dobesilic acid
- dobesilic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06763094 | N/A | Jan 5, 2025 | University of Health Sciences Lahore |
| NCT05305508 | Phase 2 | May 31, 2022 | OM Pharma, University of Geneva, University of Genoa |
| NCT06707051 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2022 | Sahiwal medical college sahiwal |
| NCT04283162 | Phase 4 | Mar 1, 2020 | Southeast University |
| NCT03427944 | Phase 4 | Jan 31, 2015 | Xuzhou Medical University |
| NCT03962296 | Phase 4 | Nov 21, 2012 | Hallym University, Hanlim Pharm. Co., Ltd., Hanyang University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hallym University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Hanlim Pharm. Co., Ltd. | For profit | 1 | 0 | 1 | 2012 |
| Hanyang University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| OM Pharma | For profit | 1 | 0 | 1 | 2022 |
| Sahiwal medical college sahiwal | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Southeast University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Geneva | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Genoa | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Health Sciences Lahore | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Xuzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2015 |
10 organizations
Page 1 / 1